Global Betahistine Market Research Report 2020

Global Betahistine Market Research Report 2020

Table of Contents
1 Betahistine Market Overview
1.1 Product Overview and Scope of Betahistine
1.2 Betahistine Segment by Type
1.2.1 Global Betahistine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 8mg
1.2.3 25mg
1.2.4 Others
1.3 Betahistine Segment by Application
1.3.1 Betahistine Sales Comparison by Application: 2020 VS 2026
1.3.2 Cerebral Thrombosis
1.3.3 Cerebral Embolism
1.3.4 Others
1.4 Global Betahistine Market Size Estimates and Forecasts
1.4.1 Global Betahistine Revenue 2015-2026
1.4.2 Global Betahistine Sales 2015-2026
1.4.3 Betahistine Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Betahistine Industry Impact
1.5.1 How the Covid-19 is Affecting the Betahistine Industry
1.5.1.1 Betahistine Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Betahistine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Betahistine Players to Combat Covid-19 Impact
2 Global Betahistine Market Competition by Manufacturers
2.1 Global Betahistine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Betahistine Revenue Share by Manufacturers (2015-2020)
2.3 Global Betahistine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Betahistine Manufacturing Sites, Area Served, Product Type
2.5 Betahistine Market Competitive Situation and Trends
2.5.1 Betahistine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Betahistine Players (Opinion Leaders)
3 Betahistine Retrospective Market Scenario by Region
3.1 Global Betahistine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Betahistine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Betahistine Market Facts & Figures by Country
3.3.1 North America Betahistine Sales by Country
3.3.2 North America Betahistine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Betahistine Market Facts & Figures by Country
3.4.1 Europe Betahistine Sales by Country
3.4.2 Europe Betahistine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Betahistine Market Facts & Figures by Region
3.5.1 Asia Pacific Betahistine Sales by Region
3.5.2 Asia Pacific Betahistine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Betahistine Market Facts & Figures by Country
3.6.1 Latin America Betahistine Sales by Country
3.6.2 Latin America Betahistine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Betahistine Market Facts & Figures by Country
3.7.1 Middle East and Africa Betahistine Sales by Country
3.7.2 Middle East and Africa Betahistine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Betahistine Historic Market Analysis by Type
4.1 Global Betahistine Sales Market Share by Type (2015-2020)
4.2 Global Betahistine Revenue Market Share by Type (2015-2020)
4.3 Global Betahistine Price Market Share by Type (2015-2020)
4.4 Global Betahistine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Betahistine Historic Market Analysis by Application
5.1 Global Betahistine Sales Market Share by Application (2015-2020)
5.2 Global Betahistine Revenue Market Share by Application (2015-2020)
5.3 Global Betahistine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Betahistine Business
6.1 TOWA PHARMACEUTICAL CO., LTD
6.1.1 Corporation Information
6.1.2 TOWA PHARMACEUTICAL CO., LTD Description, Business Overview and Total Revenue
6.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 TOWA PHARMACEUTICAL CO., LTD Products Offered
6.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Development
6.2 Nichi-Iko Pharmaceutical
6.2.1 Nichi-Iko Pharmaceutical Corporation Information
6.2.2 Nichi-Iko Pharmaceutical Description, Business Overview and Total Revenue
6.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Nichi-Iko Pharmaceutical Products Offered
6.2.5 Nichi-Iko Pharmaceutical Recent Development
6.3 Takeda Pharmaceutical Company Limited
6.3.1 Takeda Pharmaceutical Company Limited Corporation Information
6.3.2 Takeda Pharmaceutical Company Limited Description, Business Overview and Total Revenue
6.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Takeda Pharmaceutical Company Limited Products Offered
6.3.5 Takeda Pharmaceutical Company Limited Recent Development
6.4 EA Pharma Co., Ltd.
6.4.1 EA Pharma Co., Ltd. Corporation Information
6.4.2 EA Pharma Co., Ltd. Description, Business Overview and Total Revenue
6.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 EA Pharma Co., Ltd. Products Offered
6.4.5 EA Pharma Co., Ltd. Recent Development
6.5 Disphar International B.V.
6.5.1 Disphar International B.V. Corporation Information
6.5.2 Disphar International B.V. Description, Business Overview and Total Revenue
6.5.3 Disphar International B.V. Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Disphar International B.V. Products Offered
6.5.5 Disphar International B.V. Recent Development
6.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
6.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
6.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Description, Business Overview and Total Revenue
6.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Products Offered
6.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Development
6.7 DOC Generici
6.6.1 DOC Generici Corporation Information
6.6.2 DOC Generici Description, Business Overview and Total Revenue
6.6.3 DOC Generici Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 DOC Generici Products Offered
6.7.5 DOC Generici Recent Development
6.8 Ciclum Farma Unipessoal
6.8.1 Ciclum Farma Unipessoal Corporation Information
6.8.2 Ciclum Farma Unipessoal Description, Business Overview and Total Revenue
6.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Ciclum Farma Unipessoal Products Offered
6.8.5 Ciclum Farma Unipessoal Recent Development
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description, Business Overview and Total Revenue
6.9.3 Mylan Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Mylan Products Offered
6.9.5 Mylan Recent Development
6.10 Orion Corporation
6.10.1 Orion Corporation Corporation Information
6.10.2 Orion Corporation Description, Business Overview and Total Revenue
6.10.3 Orion Corporation Betahistine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Orion Corporation Products Offered
6.10.5 Orion Corporation Recent Development
7 Betahistine Manufacturing Cost Analysis
7.1 Betahistine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Betahistine
7.4 Betahistine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Betahistine Distributors List
8.3 Betahistine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Betahistine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Betahistine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Betahistine by Type (2021-2026)
10.2 Betahistine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Betahistine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Betahistine by Application (2021-2026)
10.3 Betahistine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Betahistine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Betahistine by Region (2021-2026)
10.4 North America Betahistine Estimates and Projections (2021-2026)
10.5 Europe Betahistine Estimates and Projections (2021-2026)
10.6 Asia Pacific Betahistine Estimates and Projections (2021-2026)
10.7 Latin America Betahistine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Betahistine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Betahistine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Betahistine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Betahistine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Betahistine Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Betahistine Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Betahistine Players to Combat Covid-19 Impact
Table 9. Global Key Betahistine Manufacturers Covered in This Study
Table 10. Global Betahistine Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Betahistine Sales Share by Manufacturers (2015-2020)
Table 12. Global Betahistine Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Betahistine Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Betahistine Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Betahistine Sales Sites and Area Served
Table 16. Manufacturers Betahistine Product Types
Table 17. Global Betahistine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Betahistine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Betahistine as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Betahistine Players
Table 21. Global Betahistine Sales (K Units) by Region (2015-2020)
Table 22. Global Betahistine Sales Market Share by Region (2015-2020)
Table 23. Global Betahistine Revenue (Million US$) by Region (2015-2020)
Table 24. Global Betahistine Revenue Market Share by Region (2015-2020)
Table 25. North America Betahistine Sales by Country (2015-2020) (K Units)
Table 26. North America Betahistine Sales Market Share by Country (2015-2020)
Table 27. North America Betahistine Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Betahistine Revenue Market Share by Country (2015-2020)
Table 29. Europe Betahistine Sales by Country (2015-2020) (K Units)
Table 30. Europe Betahistine Sales Market Share by Country (2015-2020)
Table 31. Europe Betahistine Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Betahistine Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Betahistine Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Betahistine Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Betahistine Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Betahistine Revenue Market Share by Region (2015-2020)
Table 37. Latin America Betahistine Sales by Country (2015-2020) (K Units)
Table 38. Latin America Betahistine Sales Market Share by Country (2015-2020)
Table 39. Latin America Betahistine Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Betahistine Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Betahistine Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Betahistine Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Betahistine Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Betahistine Revenue Market Share by Country (2015-2020)
Table 45. Global Betahistine Sales (K Units) by Type (2015-2020)
Table 46. Global Betahistine Sales Share by Type (2015-2020)
Table 47. Global Betahistine Revenue (Million US$) by Type (2015-2020)
Table 48. Global Betahistine Revenue Share by Type (2015-2020)
Table 49. Global Betahistine Price (US$/Unit) by Type (2015-2020)
Table 50. Global Betahistine Sales (K Units) by Application (2015-2020)
Table 51. Global Betahistine Sales Market Share by Application (2015-2020)
Table 52. Global Betahistine Sales Growth Rate by Application (2015-2020)
Table 53. TOWA PHARMACEUTICAL CO., LTD Betahistine Corporation Information
Table 54. TOWA PHARMACEUTICAL CO., LTD Description and Business Overview
Table 55. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. TOWA PHARMACEUTICAL CO., LTD Main Product
Table 57. TOWA PHARMACEUTICAL CO., LTD Recent Development
Table 58. Nichi-Iko Pharmaceutical Betahistine Corporation Information
Table 59. Nichi-Iko Pharmaceutical Corporation Information
Table 60. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Nichi-Iko Pharmaceutical Main Product
Table 62. Nichi-Iko Pharmaceutical Recent Development
Table 63. Takeda Pharmaceutical Company Limited Betahistine Corporation Information
Table 64. Takeda Pharmaceutical Company Limited Corporation Information
Table 65. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Takeda Pharmaceutical Company Limited Main Product
Table 67. Takeda Pharmaceutical Company Limited Recent Development
Table 68. EA Pharma Co., Ltd. Betahistine Corporation Information
Table 69. EA Pharma Co., Ltd. Corporation Information
Table 70. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. EA Pharma Co., Ltd. Main Product
Table 72. EA Pharma Co., Ltd. Recent Development
Table 73. Disphar International B.V. Betahistine Corporation Information
Table 74. Disphar International B.V. Corporation Information
Table 75. Disphar International B.V. Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Disphar International B.V. Main Product
Table 77. Disphar International B.V. Recent Development
Table 78. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Corporation Information
Table 79. HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
Table 80. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. HENNIG ARZNEIMITTEL GmbH & Co. KG Main Product
Table 82. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Development
Table 83. DOC Generici Betahistine Corporation Information
Table 84. DOC Generici Corporation Information
Table 85. DOC Generici Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. DOC Generici Main Product
Table 87. DOC Generici Recent Development
Table 88. Ciclum Farma Unipessoal Betahistine Corporation Information
Table 89. Ciclum Farma Unipessoal Corporation Information
Table 90. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Ciclum Farma Unipessoal Main Product
Table 92. Ciclum Farma Unipessoal Recent Development
Table 93. Mylan Betahistine Corporation Information
Table 94. Mylan Corporation Information
Table 95. Mylan Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Mylan Main Product
Table 97. Mylan Recent Development
Table 98. Orion Corporation Betahistine Corporation Information
Table 99. Orion Corporation Corporation Information
Table 100. Orion Corporation Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Orion Corporation Main Product
Table 102. Orion Corporation Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Betahistine Distributors List
Table 106. Betahistine Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Betahistine Sales (K Units) Forecast by Type (2021-2026)
Table 111. Global Betahistine Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Betahistine Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Betahistine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Betahistine Sales (K Units) Forecast by Application (2021-2026)
Table 115. Global Betahistine Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Betahistine Sales (K Units) Forecast by Region (2021-2026)
Table 117. Global Betahistine Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Betahistine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Betahistine Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Betahistine
Figure 2. Global Betahistine Sales Market Share by Type: 2020 VS 2026
Figure 3. 8mg Product Picture
Figure 4. 25mg Product Picture
Figure 5. Others Product Picture
Figure 6. Global Betahistine Consumption Market Share by Application: 2020 VS 2026
Figure 7. Cerebral Thrombosis
Figure 8. Cerebral Embolism
Figure 9. Others
Figure 10. Global Betahistine Market Size 2015-2026 (US$ Million)
Figure 11. Global Betahistine Sales Capacity (K Units) (2015-2026)
Figure 12. Global Betahistine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Betahistine Sales Share by Manufacturers in 2020
Figure 14. Global Betahistine Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Betahistine Revenue in 2019
Figure 16. Betahistine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Betahistine Sales Market Share by Region (2015-2020)
Figure 18. Global Betahistine Sales Market Share by Region in 2019
Figure 19. Global Betahistine Revenue Market Share by Region (2015-2020)
Figure 20. Global Betahistine Revenue Market Share by Region in 2019
Figure 21. North America Betahistine Sales Market Share by Country in 2019
Figure 22. North America Betahistine Revenue Market Share by Country in 2019
Figure 23. U.S. Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Betahistine Sales Market Share by Country in 2019
Figure 28. Europe Betahistine Revenue Market Share by Country in 2019
Figure 29. Germany Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Betahistine Sales Market Share by Region in 2019
Figure 40. Asia Pacific Betahistine Revenue Market Share by Region in 2019
Figure 41. China Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Betahistine Sales Market Share by Country in 2019
Figure 64. Latin America Betahistine Revenue Market Share by Country in 2019
Figure 65. Mexico Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Betahistine Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Betahistine Revenue Market Share by Country in 2019
Figure 73. Turkey Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Betahistine Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Betahistine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Betahistine by Type (2015-2020)
Figure 80. Sales Market Share of Betahistine by Type in 2019
Figure 81. Revenue Share of Betahistine by Type (2015-2020)
Figure 82. Revenue Market Share of Betahistine by Type in 2019
Figure 83. Global Betahistine Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Betahistine Sales Market Share by Application (2015-2020)
Figure 85. Global Betahistine Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Betahistine by Application (2015-2020)
Figure 87. Global Revenue Share of Betahistine by Application in 2020
Figure 88. TOWA PHARMACEUTICAL CO., LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Nichi-Iko Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Takeda Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. EA Pharma Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Disphar International B.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. HENNIG ARZNEIMITTEL GmbH & Co. KG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. DOC Generici Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Ciclum Farma Unipessoal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Orion Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Betahistine
Figure 100. Manufacturing Process Analysis of Betahistine
Figure 101. Betahistine Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Betahistine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Betahistine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Betahistine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Betahistine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Betahistine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Betahistine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Betahistine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Betahistine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Betahistine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Betahistine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs